Rotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment
4 affiliations
- 1Faculty of Medicine, University of Oslo, Oslo, Norway
- 2Department of Paediatric Research, University of Oslo, Oslo, Norway
- 3Department of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
- 4Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Abstract
Aims/hypothesis: Environmental factors, including infections, have been suspected to influence the risk of type 1 diabetes. Studies of rotavirus vaccine and risk of type 1 diabetes have shown conflicting results. We took advantage of the rapid and high uptake of the rotavirus vaccine among infants in Norway as a natural experiment to study the potential association between rotavirus vaccination and type 1 diabetes incidence in Norway.
Methods: In this cohort study, we followed all children born in Norway during 2007–2019 from 6 months to 5 years of age for type 1 diabetes. In an interrupted time series analysis, we compared type 1 diabetes incidence in children born before compared with after introduction of the rotavirus vaccination programme in September 2014.
Results: Of 740,744 included children, 846 were diagnosed with type 1 diabetes between 6 months and 5 years of age. Our primary interrupted time series analysis showed an increasing trend after implementation of the rotavirus vaccination programme (relative HR 1.11 [95% CI 1.03, 1.20]), which was not significant after excluding birth cohorts from 2013–2015 to avoid potential herd immunity effects (relative HR 1.05 [95% CI 0.93, 1.18]). In a secondary analysis comparing fully vaccinated with non-vaccinated children, the adjusted HR was 1.17 (95% CI 0.78, 1.77).
Conclusions/Interpretation: This study found no evidence for a reduced risk of type 1 diabetes after introduction of rotavirus vaccination in infancy.
Graphical Abstract:
Supplementary Information: The online version contains peer-reviewed but unedited supplementary material available at https://doi.org/10.1007/s00125-026-06832-0.
Related
- The Enigma of Finnish and Sardinian Type 1 Diabetes Incidence: Where Population History Meets Genetics
- Population Intelligence: Smallest-Model Numerical Experiment
- Depressive symptoms are associated with the incidence of frailty in older adults with cardiometabolic diseases: Interaction between depression and diabetes
- Higher intake of dietary dicarbonyl compounds is associated with lower incidence of type 2 diabetes: European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study
- Association between diabetes mellitus and hearing impairment in the adult Canadian population: data from the Canadian longitudinal study on aging
BibTeX
@article{ostman2026rotavirus,
title = {{Rotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment}},
author = {Maria Östman and Ketil Størdal and German Tapia and Lars C. Stene},
journal = {Diabetologia},
year = {2026},
month = aug,
doi = {10.1007/s00125-026-06832-0},
url = {https://doi.org/10.1007/s00125-026-06832-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Rotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment
AU - Maria Östman
AU - Ketil Størdal
AU - German Tapia
AU - Lars C. Stene
PY - 2026
DA - 2026/08/28
JO - Diabetologia
DO - 10.1007/s00125-026-06832-0
UR - https://doi.org/10.1007/s00125-026-06832-0
AB - Aims/hypothesis: Environmental factors, including infections, have been suspected to influence the risk of type 1 diabetes. Studies of rotavirus vaccine and risk of type 1 diabetes have shown conflicting results. We took advantage of the rapid and high uptake of the rotavirus vaccine among infants in Norway as a natural experiment to study the potential association between rotavirus vaccination and type 1 diabetes incidence in Norway. Methods: In this cohort study, we followed all children born in Norway during 2007–2019 from 6 months to 5 years of age for type 1 diabetes. In an interrupted time series analysis, we compared type 1 diabetes incidence in children born before compared with after introduction of the rotavirus vaccination programme in September 2014. Results: Of 740,744 included children, 846 were diagnosed with type 1 diabetes between 6 months and 5 years of age. Our primary interrupted time series analysis showed an increasing trend after implementation of the rotavirus vaccination programme (relative HR 1.11 [95% CI 1.03, 1.20]), which was not significant after excluding birth cohorts from 2013–2015 to avoid potential herd immunity effects (relative HR 1.05 [95% CI 0.93, 1.18]). In a secondary analysis comparing fully vaccinated with non-vaccinated children, the adjusted HR was 1.17 (95% CI 0.78, 1.77). Conclusions/Interpretation: This study found no evidence for a reduced risk of type 1 diabetes after introduction of rotavirus vaccination in infancy. Graphical Abstract: Supplementary Information: The online version contains peer-reviewed but unedited supplementary material available at https://doi.org/10.1007/s00125-026-06832-0.
SN - 0012-186X
SN - 1432-0428
ER -